| Alere Mycobacterium Tuberculosis Urine Study (NCT01585532) | Research Center Borstel | 2012-01-01 |
| The Effect of Intermittent Rifampicin on Raltegravir (NCT01424826) | Helen Reynolds | 2012-01-01 |
| EARNEST Rifabutin Pharmacokinetics (PK) Substudy (NCT01663168) | Justine Boles | 2011-12-01 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease (NCT01424501) | GlaxoSmithKline | 2011-11-14 |
| Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa (NCT01479972) | Serum Life Science Europe GmbH | 2011-11-01 |
| TMC207 +/- Rifabutin/Rifampin (NCT01341184) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-21 |
| Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho (NCT01459120) | SolidarMed | 2011-10-01 |
| Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV (NCT02043067) | University of North Carolina, Chapel Hill | 2011-10-01 |
| Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting (NCT01053598) | Epicentre | 2011-09-01 |
| Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route (NCT01497769) | University of Oxford | 2011-09-01 |
| Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis Drugs (NCT01436929) | Seoul National University Hospital | 2011-09-01 |
| Tuberculosis (TB) Immunotherapy Phase 2 Study (NCT01380119) | Lisichansk Regional Tuberculosis Dispensary | 2011-08-01 |
| PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay (NCT01225640) | Sequella, Inc. | 2011-08-01 |
| Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment (NCT01417988) | Prof JMA Lange | 2011-08-01 |
| Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) (NCT01151189) | Aeras | 2011-07-01 |
| Training Protocol on the Natural History of Tuberculosis (NCT01212003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-30 |
| Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals (NCT03042754) | The HIV Netherlands Australia Thailand Research Collaboration | 2011-06-06 |
| Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers (NCT01376843) | Yonsei University | 2011-06-01 |
| Access to Care and Adherence Tuberculosis (TB) Survey (NCT01390987) | Azienda Ospedaliera San Gerardo di Monza | 2011-06-01 |
| Tiotropium in Patients With Tuberculosis (TB) Destroyed Lung (NCT01365702) | Seoul National University Bundang Hospital | 2011-06-01 |
| Pharmacokinetics and Safety of Moxifloxacin (NCT01329250) | University Medical Center Groningen | 2011-05-01 |
| Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa (NCT01693224) | Tuberculosis Clinical Diagnostics Research Consortium | 2011-04-01 |
| Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon) (NCT01331811) | ANRS, Emerging Infectious Diseases | 2011-04-01 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG (NCT01242475) | Statens Serum Institut | 2011-04-01 |
| Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) (NCT01311505) | Pfizer | 2011-04-01 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (NCT01241188) | Statens Serum Institut | 2011-04-01 |
| Pharmacogenetics of Vitamin D Supplementation in Tuberculosis (NCT01722396) | University of Birmingham | 2011-03-01 |
| Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis (NCT03137875) | Epicentre | 2011-03-01 |
| Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment Outcomes (NCT01690754) | Interactive Research and Development | 2011-03-01 |
| A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi (NCT01356095) | Dignitas International | 2011-03-01 |
| Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis (NCT01301144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-02-13 |
| Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in Infants (NCT01288950) | University of California, San Diego | 2011-02-01 |
| A Study to Evaluate Safety and Immunogenicity of AERAS-402 (NCT01378312) | Aeras | 2011-02-01 |
| Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults (NCT01262976) | GlaxoSmithKline | 2011-01-17 |
| A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (NCT02420444) | Aeras | 2011-01-01 |
| Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis (NCT01525134) | Tuberculosis Clinical Diagnostics Research Consortium | 2011-01-01 |
| Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (NCT03458338) | University Hospital, Basel, Switzerland | 2010-12-08 |
| Labial Biopsy in Patients With Tuberculosis Disease (NCT02115854) | Hopital Lariboisière | 2010-12-01 |
| Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph Nodes (NCT01350674) | Centre Hospitalier Universitaire Saint Pierre | 2010-12-01 |
| Study of AERAS 422 in Healthy Adults (NCT01340820) | Aeras | 2010-12-01 |
| Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary Tuberculosis (NCT01517022) | All India Institute of Medical Sciences | 2010-11-01 |
| Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis (NCT01223976) | Tel-Aviv Sourasky Medical Center | 2010-11-01 |
| Phase IC Study of Safety and PK of SQ109 300mg Daily (NCT01358162) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-01 |
| Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy (NCT01138202) | The HIV Netherlands Australia Thailand Research Collaboration | 2010-11-01 |
| Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination (NCT01119521) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Trial of Point-of-treatment Xpert MTB/RIF Assay (NCT01554384) | University of Cape Town | 2010-10-01 |
| Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients (NCT01059422) | Central Institute of Epidemiology, Moscow, Russia | 2010-10-01 |
| Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients (NCT01364324) | National Cancer Center, Korea | 2010-09-01 |
| Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia (NCT01252537) | Lund University | 2010-09-01 |
| Study of AERAS-402 in Healthy Infants (NCT01198366) | Aeras | 2010-09-01 |
| Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients (NCT01530568) | University of Cape Town | 2010-08-01 |
| Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity (NCT01456845) | All India Institute of Medical Sciences | 2010-08-01 |
| Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants (NCT01098474) | GlaxoSmithKline | 2010-07-07 |
| Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens (NCT01322685) | Taipei Medical University WanFang Hospital | 2010-07-01 |
| The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective Study (NCT01167647) | Meir Medical Center | 2010-07-01 |
| Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations (NCT01167452) | Texas Tech University Health Sciences Center | 2010-07-01 |
| Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis (NCT00760149) | Radboud University Medical Center | 2010-07-01 |
| Effect of Weight and/or Obesity on Dapsone Drug Concentrations (NCT01165840) | Texas Tech University Health Sciences Center | 2010-07-01 |
| Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection (NCT01136161) | Archivel Farma S.L. | 2010-06-01 |
| Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam (NCT00651066) | French National Agency for Research on AIDS and Viral Hepatitis | 2010-06-01 |
| A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85A (NCT01194180) | University of Oxford | 2010-05-01 |
| Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients (NCT01121068) | Seoul National University Hospital | 2010-05-01 |
| Study of Daily Rifapentine for Pulmonary Tuberculosis (NCT00814671) | Johns Hopkins University | 2010-04-01 |
| Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa (NCT01113281) | Serum Life Science Europe GmbH | 2010-04-01 |
| Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers (NCT01162486) | Johns Hopkins University | 2010-04-01 |
| PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002) (NCT02216331) | Global Alliance for TB Drug Development | 2010-03-01 |
| Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis (NCT01131351) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-02-19 |
| Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children (NCT00802802) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-10 |
| Tuberculosis in China (NCT01071603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-02-02 |
| Latent Tuberculosis Infection in Bone Marrow Transplant Recipients (NCT01021124) | Asan Medical Center | 2010-01-01 |
| Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIV (NCT01061593) | Lisichansk Regional Tuberculosis Dispensary | 2010-01-01 |
| Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB (NCT01099098) | Seoul National University Hospital | 2010-01-01 |
| The Impact of Vitamin D on Tuberculosis Among Koreans (NCT01137370) | Seoul National University Hospital | 2010-01-01 |
| Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort (NCT03822156) | University of Ulsan | 2010-01-01 |
| Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients (NCT01222338) | Lisichansk Regional Tuberculosis Dispensary | 2010-01-01 |
| Effect of Weight and/or Obesity on Ethambutol Drug Concentrations (NCT01048697) | Texas Tech University Health Sciences Center | 2010-01-01 |
| A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active Tuberculosis (NCT01033929) | Statens Serum Institut | 2010-01-01 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents (NCT00950612) | GlaxoSmithKline | 2009-12-08 |
| Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam (NCT01768273) | Global Alliance for TB Drug Development | 2009-12-01 |
| Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy Volunteers (NCT00992069) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals (NCT00865826) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-12-01 |
| Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults (NCT01017536) | Aeras | 2009-12-01 |
| Role of Vitamin D in Innate Immunity to Tuberculosis (NCT01244204) | Harvard School of Public Health (HSPH) | 2009-11-01 |
| Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy (NCT01539005) | Centre for the AIDS Programme of Research in South Africa | 2009-11-01 |
| Study of Latent Tuberculosis Infection (LTBI) by High Resolution Scanner (NCT00904956) | Germans Trias i Pujol Hospital | 2009-11-01 |
| Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers (NCT00990990) | Sequella, Inc. | 2009-10-01 |
| A Leukapheresis Study for Immune Responses in Healthy US Adults Who Receive BCG Vaccination Followed by Boosting With AERAS-402 (NCT02375256) | Aeras | 2009-10-01 |
| Appropriate Timing of HAART in Co-infected HIV/TB Patients (NCT01014481) | Bamrasnaradura Infectious Diseases Institute | 2009-10-01 |
| Effectiveness of Music Therapy (NCT01040611) | Taipei Medical University WanFang Hospital | 2009-10-01 |
| The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective Study (NCT01182259) | E-DA Hospital | 2009-10-01 |
| Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccine Ag85B-ESAT-6 as Two Injections With Two Months Interval to Healthy Adult Volunteers (NCT00922363) | Statens Serum Institut | 2009-10-01 |
| Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-009) (NCT01830439) | Global Alliance for TB Drug Development | 2009-09-01 |
| To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB. (NCT00910871) | Janssen Infectious Diseases BVBA | 2009-09-01 |
| Vicente Ferrer HIV Cohort Study (NCT02454569) | Rural Development Trust Hospital | 2009-09-01 |
| Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care Setting (NCT01545661) | University of Cape Town | 2009-08-01 |
| A Study of MVA85A in Healthy Infants (NCT00953927) | Aeras | 2009-07-01 |
| Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients (NCT00962676) | Yonsei University | 2009-07-01 |
| Impact of Vitamin D Supplementation on Host Immunity to Mycobacterium Tuberculosis and Response to Treatment (NCT00918086) | Emory University | 2009-07-01 |
| Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (NCT00822315) | ANRS, Emerging Infectious Diseases | 2009-07-01 |
| A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY) (NCT00932854) | University College London Hospitals | 2009-07-01 |